3rd Quarter - Report

ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) for ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

On September 17th, 21st, & 25th ADLM initiated a grassroots campaign in support of including $5 million for the Centers for Disease Control and Prevention to improve pediatric reference intervals in the fY2027 spending package.

LobbyistCovered position, as disclosed
VINCENT STINE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

* On April 10, ADLM joined with other healthcare entities in endorsing H.R.8500, the Timely Access to Coverage Decisions Act, which would create a more transparent Medicare process for making coverage decisions. On July 20th and September 24th, ADLM initiated grassroots campaigns in support of H.R.5269 & S.2761, the RESULTS Act, which would revise the Medicare Clinical Laboratory Fee Schedule.

LobbyistCovered position, as disclosed
VINCENT STINE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5269 (119th), S. 2761 (119th), H.R. 8500 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.